The conference will cover drug and treatment updates with a focus on precision medicine, gynecological malignancies, hematologic malignancies, prostate, bladder cancer and GI malignancies. The conference features a comprehensive review of new drugs approved along with their mechanism of action, and a keynote lecture, Stand Up to Cancer focusing on developmental therapeutics. Next generation studies will also be addressed, and the conference will offer participants a session designed to provide insight into the latest advances in lung cancer treatment, including integration of new molecularly-targeted therapies and immunotherapy. URLs:Twitter: https://go.evvnt.com/2523190-2?pid=5569LinkedIn: https://go.evvnt.com/2523190-3?pid=5569 Date and Time: Friday, 15 November 2024 at 14:00 to Saturday, 16 November 2024 at 16:30 Venue details: Sofitel Los Angeles at Beverly Hills, 8555 Beverly Boulevard, Los Angeles, California, 90048, United States Category: Conferences | Science, Health and Medicine | CME (Continuing Medical Education) Prices:Physicians: USD 125.00,All Other Healthcare Providers: USD 100.00,Residents/Fellows/Medical Students: USD 0.00,CSHS Advanced Practice Providers/Researchers/Administration: USD 0.00,Industry: USD 225.00 Speakers: John Chute, MD, Robert A. Figlin, MD, Karen Reckamp, MD